Page last updated: 2024-08-17

quinoxalines and caroverine

quinoxalines has been researched along with caroverine in 38 studies

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19906 (15.79)18.7374
1990's9 (23.68)18.2507
2000's19 (50.00)29.6817
2010's3 (7.89)24.3611
2020's1 (2.63)2.80

Authors

AuthorsStudies
Ehrenberger, K; Felix, D2
Eberhardt, G; Haller, R; König, P; Koppi, S1
Ishida, M; Shinozaki, H1
Kudo, Y; Shibata, S1
Iida, H; Sakurai, Y; Tsukagoshi, S; Tsuruo, T1
Ishida, Y; Ozaki, H; Shibata, S1
Anderer, P; Grünberger, J; König, P; Linzmayer, L; Saletu, B2
Denk, DM; Ehrenberger, K; Franz, P; Heinzl, H1
Fartacek, R; Geretsegger, C1
Domeisen, H; Häusler, R; Hotz, MA1
Arnold, W; Ehrenberger, K; Felix, D; Oestreicher, E1
Conca, A; König, P; Lugmayer, B1
Ehrenberger, K2
Ehrenberger, K; Felix, D; Oestreicher, E1
Bieberschulte, W; Ehrenberger, K; Frei, K; Kozlov, AV; Nohl, H; Udilova, N1
Ehrenberger, K; Hummel, T; Quint, C; Temmel, AF1
Hummel, T1
Kratzer, U; Schmidt, WJ1
HITZENBERGER, G; HORNYKIEWICZ, O; ZELLNER, H1
Chen, Z; Duan, M; Ruan, R; Tan, L; Ulfendahl, M2
Bieberschulte, W; Dietrich, B; Kozlov, AV; Nohl, H; Udilova, N1
Temmel, AF; Toth, J1
Heermann, R; Lenarz, T; Schwab, B1
Alpini, D; Capobianco, S; Cesarani, A; Giuliano, DA1
Bieberschulte, W; Gille, L; Jurek, D; Marian, B; Nohl, H; Rohr-Udilova, N; Schulte-Hermann, R1
Borg, E; Chen, Z; Duan, M; Laurell, G; Qiu, J; Ruan, R; Ulfendahl, M1
Born, J; Gais, S; Rasch, B; Wagner, U1
Logvinov, SV; Plotnikov, MB; Potapov, AV; Varakuta, EIu; Zhdankina, AA1
Logvinov, SV; Plotnikov, MB; Potapov, AV; Varakuta, EY; Zhdankina, AA1
Born, J; Hallschmid, M; Hubold, C; Klement, J; Knispel, A; Oltmanns, KM; Pais, I; Peters, A; Schultes, B1
Brunner, M; Enzenhofer, E; Haymerle, G; Heiduschka, G; Kadletz, L; Kotowski, U; Stanisz, I; Thurnher, D1
Harless, L; Liang, J1
Ansari, TM; Raza, A1
Aeumjaturapat, S; Chusakul, S; Kanjanaumporn, J; Seresirikachorn, K; Snidvongs, K1

Reviews

3 review(s) available for quinoxalines and caroverine

ArticleYear
[Drug therapy for disturbances of smelling].
    Laryngo- rhino- otologie, 2004, Volume: 83, Issue:2

    Topics: Adrenal Cortex Hormones; Controlled Clinical Trials as Topic; Dopamine; Humans; Olfaction Disorders; Quinoxalines; Smell; Theophylline; Vasodilator Agents; Vitamin A; Vitamin B Complex; Zinc

2004
Pharmacologic treatment for postviral olfactory dysfunction: a systematic review.
    International forum of allergy & rhinology, 2016, Volume: 6, Issue:7

    Topics: Adrenal Cortex Hormones; Ginkgo biloba; Humans; Minocycline; Olfaction Disorders; Quinoxalines; Thioctic Acid; Vitamin A; Zinc Sulfate

2016
Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options.
    Asian Pacific journal of allergy and immunology, 2020, Volume: 38, Issue:2

    Topics: Adrenal Cortex Hormones; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Incidence; Olfaction Disorders; Olfactory Mucosa; Olfactory Perception; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Prognosis; Quinoxalines; Remission, Spontaneous; SARS-CoV-2; Taste Perception; Vitamin A

2020

Trials

9 trial(s) available for quinoxalines and caroverine

ArticleYear
Calcium-channel-blocking agent in the treatment of acute alcohol withdrawal--caroverine versus meprobamate in a randomized double-blind study.
    Neuropsychobiology, 1987, Volume: 17, Issue:1-2

    Topics: Adult; Aged; Alcohol Withdrawal Delirium; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Meprobamate; Middle Aged; Psychoses, Alcoholic; Quinoxalines

1987
Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Arzneimittel-Forschung, 1995, Volume: 45, Issue:3

    Topics: Administration, Oral; Adult; Analysis of Variance; Arousal; Brain Mapping; Calcium Channel Blockers; Central Nervous System Agents; Double-Blind Method; Electroencephalography; Excitatory Amino Acid Antagonists; Female; Humans; Injections, Intravenous; Male; Psychometrics; Quinoxalines

1995
On the cerebro-protective effects of caroverine, a calcium-channel blocker and antiglutamatergic drug: double-blind, placebo-controlled, EEG mapping and psychometric studies under hypoxia.
    British journal of clinical pharmacology, 1996, Volume: 41, Issue:2

    Topics: Adult; Brain; Calcium Channel Blockers; Double-Blind Method; Electroencephalography; Excitatory Amino Acid Antagonists; Female; Humans; Hypoxia; Male; Placebos; Psychometrics; Quinoxalines; Reference Values

1996
Caroverine in tinnitus treatment. A placebo-controlled blind study.
    Acta oto-laryngologica, 1997, Volume: 117, Issue:6

    Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Psychoacoustics; Quinoxalines; Single-Blind Method; Time Factors; Tinnitus

1997
Does a glutamate receptor blocker (Caroverine) enhance haloperidol in the treatment of schizophrenia?
    Neuropsychobiology, 1999, Volume: 40, Issue:3

    Topics: Adult; Antipsychotic Agents; Drug Synergism; Excitatory Amino Acid Antagonists; Female; Haloperidol; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Quinoxalines; Retrospective Studies; Schizophrenia; Schizophrenic Psychology

1999
The quinoxaline derivative caroverine in the treatment of sensorineural smell disorders: a proof-of-concept study.
    Acta oto-laryngologica, 2002, Volume: 122, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; N-Methylaspartate; Olfaction Disorders; Quinoxalines; Sensory Thresholds; Smell; Zinc Sulfate

2002
[Use of the round window micro cath for inner ear therapy - results of a placebo-controlled, prospective study on chronic tinnitus].
    Laryngo- rhino- otologie, 2004, Volume: 83, Issue:3

    Topics: Administration, Topical; Adult; Aged; Auditory Threshold; Catheters, Indwelling; Chronic Disease; Ear, Inner; Endoscopy; Female; Glutamic Acid; Humans; Infusion Pumps; Lidocaine; Loudness Perception; Male; Middle Aged; Pain Measurement; Patient Satisfaction; Quinoxalines; Round Window, Ear; Tinnitus; Treatment Outcome

2004
Visual-procedural memory consolidation during sleep blocked by glutamatergic receptor antagonists.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, May-21, Volume: 28, Issue:21

    Topics: Adult; Cross-Over Studies; Discrimination Learning; Double-Blind Method; Excitatory Amino Acid Antagonists; Humans; Ketamine; Male; Memory; Photic Stimulation; Quinoxalines; Sleep

2008
Blocking AMPA receptor signalling by caroverine infusion does not affect counter-regulation of hypoglycaemia in healthy men.
    Diabetologia, 2009, Volume: 52, Issue:6

    Topics: Adrenocorticotropic Hormone; Adult; Analysis of Variance; Blood Glucose; Double-Blind Method; Epinephrine; Glucagon; Humans; Hydrocortisone; Hypoglycemia; Infusions, Intravenous; Male; Norepinephrine; Quinoxalines; Receptors, AMPA; Signal Transduction; Young Adult

2009

Other Studies

26 other study(ies) available for quinoxalines and caroverine

ArticleYear
Caroverine depresses the activity of cochlear glutamate receptors in guinea pigs: in vivo model for drug-induced neuroprotection?
    Neuropharmacology, 1992, Volume: 31, Issue:12

    Topics: Animals; Cochlea; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Guinea Pigs; Male; Quinoxalines; Receptors, Glutamate

1992
Reduction of glutamate responses by caroverine at the crayfish neuromuscular junction.
    Brain research, 1983, Apr-25, Volume: 266, Issue:1

    Topics: Animals; Astacoidea; Evoked Potentials; Glutamates; Glutamic Acid; Neuromuscular Junction; Quinoxalines

1983
Effects of caroverine and diltiazem on synaptic responses, L-glutamate-induced depolarization and potassium efflux in the frog spinal cord.
    British journal of pharmacology, 1984, Volume: 83, Issue:3

    Topics: Animals; Benzazepines; Diltiazem; Evoked Potentials; Glutamates; Glutamic Acid; In Vitro Techniques; Microelectrodes; Motor Neurons; Neuromuscular Depolarizing Agents; Potassium; Quinoxalines; Rana catesbeiana; Spinal Nerve Roots; Synapses; Tetrodotoxin; Vasodilator Agents

1984
Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.
    Cancer research, 1982, Volume: 42, Issue:11

    Topics: Animals; Calcium Channel Blockers; Calcium-Binding Proteins; Calmodulin; Clomipramine; Doxorubicin; Drug Resistance; Kinetics; Leukemia P388; Leukemia, Experimental; Mice; Prenylamine; Quinoxalines; Trifluoperazine; Verapamil; Vincristine

1982
Vasorelaxant action of caroverine fumarate (a quinoxaline derivative), a calcium-blocking agent.
    British journal of pharmacology, 1980, Volume: 71, Issue:1

    Topics: Animals; Aorta, Thoracic; Calcium; Hindlimb; In Vitro Techniques; Potassium; Quinoxalines; Rats; Regional Blood Flow; Vasodilator Agents; Verapamil

1980
Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptors: a survey.
    Acta oto-laryngologica, 1995, Volume: 115, Issue:2

    Topics: Animals; Cochlea; Ear Diseases; Ear, Inner; gamma-Aminobutyric Acid; Guinea Pigs; Hair Cells, Auditory; Humans; Magnesium; N-Methylaspartate; Neurons, Afferent; Quinoxalines; Receptors, AMPA; Receptors, Metabotropic Glutamate

1995
Infusional high-dose application of the calcium-channel-blocking and antiglutamatergic agent caroverine in the treatment of alcohol withdrawal (DSM-III-R 291.80).
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1998, Volume: 8, Issue:3

    Topics: Adult; Alcohols; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Calcium Channel Blockers; Excitatory Amino Acid Antagonists; Female; Humans; Infusion Pumps; Infusions, Intravenous; Male; Middle Aged; N-Methylaspartate; Pilot Projects; Quinoxalines; Substance Withdrawal Syndrome

1998
Caroverine in tinnitus treatment.
    Acta oto-laryngologica, 1998, Volume: 118, Issue:4

    Topics: Female; Humans; Male; Middle Aged; Pilot Projects; Quinoxalines; Research Design; Single-Blind Method; Tinnitus

1998
New approaches for inner ear therapy with glutamate antagonists.
    Acta oto-laryngologica, 1999, Volume: 119, Issue:2

    Topics: Animals; Cochlear Diseases; Excitatory Amino Acid Antagonists; Guinea Pigs; Hair Cells, Auditory, Inner; Infusion Pumps, Implantable; Iontophoresis; Memantine; Neurons, Afferent; Quinoxalines

1999
Clinical experience with caroverine in inner ear diseases.
    Advances in oto-rhino-laryngology, 2002, Volume: 59

    Topics: Cochlea; Free Radicals; Hair Cells, Auditory, Inner; Humans; Mitochondria; Neurons, Afferent; Presbycusis; Quinoxalines; Receptors, Glutamate; Synapses; Tinnitus

2002
Different action of memantine and caroverine on glutamatergic transmission in the mammalian cochlea.
    Advances in oto-rhino-laryngology, 2002, Volume: 59

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cochlea; Dopamine Agents; Female; Glutamic Acid; Guinea Pigs; Hair Cells, Auditory, Inner; Memantine; N-Methylaspartate; Neurons, Afferent; Quinoxalines

2002
The antioxidant activity of caroverine.
    Biochemical pharmacology, 2003, Jan-01, Volume: 65, Issue:1

    Topics: Analysis of Variance; Antioxidants; Calcium Channel Blockers; Excitatory Amino Acid Antagonists; Hydroxyl Radical; Lipid Peroxidation; Quinoxalines; Superoxides; Vitamin E

2003
[Therapy of olfactory loss].
    Laryngo- rhino- otologie, 2003, Volume: 82, Issue:8

    Topics: Antioxidants; Humans; Nerve Growth Factors; Olfaction Disorders; Olfactory Nerve; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Thioctic Acid; Treatment Outcome; Zinc

2003
Caroverine inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats.
    Neuroscience letters, 2003, Oct-02, Volume: 349, Issue:2

    Topics: Analgesics, Opioid; Animals; Avoidance Learning; Conditioning, Classical; Male; Morphine; Naloxone; Narcotic Antagonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome

2003
[Experimental-pharmacological and clinical studies on a new spasmolytic "Spadon" (test name P 201-1)].
    Wiener klinische Wochenschrift, 1963, Mar-15, Volume: 75

    Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Biomedical Research; Cardiovascular Agents; Muscle Relaxants, Central; Parasympatholytics; Quinoxalines

1963
Acute treatment of noise trauma with local caroverine application in the guinea pig.
    Acta oto-laryngologica, 2003, Volume: 123, Issue:8

    Topics: Administration, Topical; Animals; Evoked Potentials, Auditory, Brain Stem; Female; Guinea Pigs; Hearing Loss, Noise-Induced; Male; Quinoxalines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Round Window, Ear; Time Factors

2003
Caroverine, a multifunctional drug with antioxidant functions.
    BioFactors (Oxford, England), 2003, Volume: 19, Issue:1-2

    Topics: Analysis of Variance; Antioxidants; Glycine max; Hydroxyl Radical; Iron; Lipid Peroxidation; Liposomes; Peroxynitrous Acid; Quinoxalines; Superoxides; Time Factors; Vitamin E

2003
Tinnitus: pharmacological topodiagnosis.
    The international tinnitus journal, 2004, Volume: 10, Issue:1

    Topics: Amantadine; Anticonvulsants; Audiometry; Auditory Perception; Carbamazepine; Diuretics; Furosemide; Humans; Hyperacusis; Quinoxalines; Tinnitus

2004
Protection of auditory function against noise trauma with local caroverine administration in guinea pigs.
    Hearing research, 2004, Volume: 197, Issue:1-2

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Auditory Threshold; Evoked Potentials, Auditory, Brain Stem; Excitatory Amino Acid Antagonists; Female; Guinea Pigs; Hearing Loss, Noise-Induced; Male; N-Methylaspartate; Noise; Quinoxalines; Random Allocation; Receptors, Glutamate

2004
Topical administration of Caroverine in somatic tinnitus treatment: proof-of-concept study.
    The international tinnitus journal, 2005, Volume: 11, Issue:1

    Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Humans; Male; Middle Aged; Neurons, Afferent; Prospective Studies; Quinoxalines; Regression Analysis; Surveys and Questionnaires; Synapses; Tinnitus; Treatment Outcome; Tympanic Membrane

2005
Ubiquinol and the papaverine derivative caroverine prevent the expression of tumour- promoting factors in adenoma and carcinoma colon cancer cells induced by dietary fat.
    BioFactors (Oxford, England), 2005, Volume: 25, Issue:1-4

    Topics: Adenoma; Carcinoma; Colonic Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dietary Fats; Gene Expression Regulation, Neoplastic; Humans; Linoleic Acids; Lipid Peroxides; Organic Chemicals; Pyrazoles; Quinoxalines; Sulfonamides; Tumor Cells, Cultured; Ubiquinone; Vascular Endothelial Growth Factor A

2005
Low-dose, long-term caroverine administration attenuates impulse noise-induced hearing loss in the rat.
    Acta oto-laryngologica, 2006, Volume: 126, Issue:11

    Topics: Animals; Antioxidants; Auditory Fatigue; Brain Stem; Dose-Response Relationship, Drug; Evoked Potentials, Auditory, Brain Stem; Hair Cells, Auditory, Inner; Hair Cells, Auditory, Outer; Hearing Loss, Noise-Induced; Injections, Subcutaneous; Quinoxalines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate

2006
[Changes of synaptoarchitecture of the retina after the light-induced damage and their correction by plant antioxidants].
    Morfologiia (Saint Petersburg, Russia), 2008, Volume: 133, Issue:1

    Topics: Administration, Oral; Animals; Antioxidants; Ascorbic Acid; Light; Male; Quercetin; Quinoxalines; Radiation Injuries, Experimental; Rats; Retina; Synapses; Treatment Outcome

2008
Changes in the synaptoarchitectonics of the retina after light-induced damage and their correction with antioxidants of plant origin.
    Neuroscience and behavioral physiology, 2009, Volume: 39, Issue:2

    Topics: Administration, Oral; Animals; Antioxidants; Ascorbic Acid; Light; Male; Quercetin; Quinoxalines; Radiation Injuries, Experimental; Rats; Retina; Synapses; Treatment Outcome

2009
Assessment of caroverine as a potential chemotherapeutical agent in HNSCC cell lines.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2015, Volume: 272, Issue:11

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cetuximab; Cisplatin; Dose-Response Relationship, Drug; Fluorouracil; Head and Neck Neoplasms; Immunohistochemistry; Mice; Quinoxalines

2015
A novel spectrophotometric determination of caroverine in pharmaceutical formulations via derivatization with Folin-ciocalteu Phenol reagent.
    Pakistan journal of pharmaceutical sciences, 2018, Volume: 31, Issue:1

    Topics: Drug Compounding; Drug Stability; Excipients; Indicators and Reagents; Limit of Detection; Molecular Structure; Molybdenum; Quinoxalines; Spectrophotometry; Tablets; Tungsten Compounds

2018